Home/Filings/4/0001169245-20-000098
4//SEC Filing

Arnold Susan Elizabeth 4

Accession 0001169245-20-000098

CIK 0001169245other

Filed

Nov 22, 7:00 PM ET

Accepted

Nov 23, 6:36 PM ET

Size

5.0 KB

Accession

0001169245-20-000098

Insider Transaction Report

Form 4
Period: 2020-11-20
Arnold Susan Elizabeth
VP, Preclinical and Chem.
Transactions
  • Award

    Common Stock

    2020-11-20$3.00/sh+4,832$14,49617,984 total
Footnotes (1)
  • [F1]These shares were acquired under the PhaseBio Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).

Issuer

PhaseBio Pharmaceuticals Inc

CIK 0001169245

Entity typeother

Related Parties

1
  • filerCIK 0001755746

Filing Metadata

Form type
4
Filed
Nov 22, 7:00 PM ET
Accepted
Nov 23, 6:36 PM ET
Size
5.0 KB